The BMJ, take heed: almost all studies have some degree of biasBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5490 (Published 21 October 2015) Cite this as: BMJ 2015;351:h5490
- Martin Toal, pharmaceutical physician1
- 1Wokingham, UK
In the section on cost effectiveness of initial drug treatment in Parkinson’s disease, Muzerengi and Clarke say that health economic studies on drugs for Parkinson’s disease were “funded by drug companies and results may be biased.” …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial